Skip to content
BREAM/SIGNALS

INSIGHT BANK · 28 LIVING CARDS

Follow a question. See what changes.

Evidence, technologies, people and the next test—connected, but not confused.

Linked entity: Carelon Health Services · Clear

Commercializationv4 · 09.23

Can Shield Bring More People into Colorectal Cancer Screening? ↗

How far will broader coverage translate into new screening and diagnostic follow-up?

Guardant announced Shield’s inclusion in EviCore guidelines, effective January 1, 2027. This is not an update to detection performance.

  1. Policy announcementRecorded
  2. January 2027 implementationScheduled
  3. Testing and paymentUnverified
  4. Follow-up colonoscopyUnverified
Additional source checked

Added planned EviCore implementation; prior clinical-performance assessment is unchanged.

NEXT CHECK

Track implementation, tests and payments, participation by previously unscreened people, and completed follow-up colonoscopies separately.

Optional readership measurement

Allow this site to record page views, reading progress, a broad referral source and the ID of a prepared editorial post link? Reading and following cards work without this. Hosting-provider traffic logs are separate. Details & settings